Search

for
Search:

GlossaryBone Mineral Density (BMD)

measurement of minerals in bones indicating their strength

Bone Mineral Density (BMD) is a measurement that indicates the amount of minerals, primarily calcium, contained in a specific volume of bone. It is used to assess bone strength and the risk of fractures, with lower BMD values suggesting weaker bones and a higher likelihood of conditions like osteoporosis. BMD is typically measured using techniques such as dual-energy X-ray absorptiometry (DEXA).

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 219 results

research Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone

417 citations, February 2004 in “The Journal of Clinical Endocrinology and Metabolism”

Testosterone therapy increases bone density in older men with low testosterone levels.

Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria

research Physical Changes, Laboratory Parameters, and Bone Mineral Density During Testosterone Treatment in Adolescents with Gender Dysphoria

71 citations, August 2019 in “The journal of sexual medicine”

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess

research Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess

26 citations, January 1994 in “Hormone and Metabolic Research”

Taking spironolactone and linestrenol for androgen excess can lead to lower bone density in young women.

research Bone Mineral Density in Hyperandrogenic Amenorrhea

22 citations, June 1993 in “Calcified Tissue International”

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

research Bone Mineral Density in Patients with Alopecia Areata Treated with Long-Term Intralesional Corticosteroids

14 citations, February 2013 in “PubMed”

Patients treated with long-term intralesional corticosteroids for alopecia areata should be monitored for bone density changes and advised on osteoporosis prevention.

View more "bmd" in research →

Community Join

2 / 2 results

community 2020 Hair and Scalp Treatments: A Clinical Guide (in Depth 350 Page Guide)

in Treatment 64 upvotes 4 years ago

Treatments for hair loss, including topical immunotherapy, regenerative treatments, laser and light-based therapies, oral supplements, intralesional steroids, and new drugs like finasteride and minoxidil.

community Topical finasteride now the safest possible path?

in Finasteride/Dutasteride 82 upvotes 5 months ago

Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.